multiple congenital anomalies-hypotonia-seizures syndrome 1

Summary
Definition
A multiple congenital anomalies-hypotonia-seizures syndrome that is characterized by neonatal hypotonia, lack of psychomotor development, seizures, dysmorphic features, and variable congenital anomalies involving the cardiac, urinary, and gastrointestinal systems and has_material_basis_in homozygous mutation in the PIGN gene on chromosome 18q21.
Super Class
autosomal recessive disease multiple congenital anomalies-hypotonia-seizures syndrome
Disease Ontology
DOID:0080138
Mondo Disease Ontology
OMIM
Related Genes
Displaying 1 entry
Gene ID Gene Symbol Description Source
23556 PIGN phosphatidylinositol glycan anchor biosynthesis class N
Displaying 1 entry
Gene ID Gene Symbol Description Source
171881 pign-1 GPI ethanolamine phosphate transferase 1
Displaying 1 entry
Gene ID Gene Symbol Description Source
853690 MCD4 mannose-ethanolamine phosphotransferase MCD4
Related Glycoprotein
Displaying 1 entry
UniProt ID Protein Name Source
O95427 GPI ethanolamine phosphate transferase 1
The Human Phenotype Ontology
Displaying entries 1 - 10 of 117 in total
HPO ID HPO Term
HP:0000034 Hydrocele testis
HP:0000072 Hydroureter
HP:0000126 Hydronephrosis
HP:0000154 Wide mouth
HP:0000160 Narrow mouth
HP:0000212 Gingival overgrowth
HP:0000218 High palate
HP:0000219 Thin upper lip vermilion
HP:0000269 Prominent occiput
HP:0000280 Coarse facial features
Displaying 1 entry
Gene ID Gene Symbol Description
23556 PIGN phosphatidylinositol glycan anchor biosynthesis class N

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024